Literature DB >> 16476089

Pain and functional limitations in patients with severe haemophilia.

F R van Genderen1, K Fischer, L Heijnen, P de Kleijn, H M van den Berg, P J M Helders, N L U van Meeteren.   

Abstract

Patients with severe haemophilia often experience pain caused by haemophilic arthropathy, and it is known that pain acts as a predictor of disability. The role of pain in functional limitations in these patients, however, has not been systematically investigated. The aim of this study was to describe pain as experienced by patients with haemophilia and to address the role of pain in subsequent functional limitations. Seventy-eight adult patients (18-70 years) with severe haemophilia completed one questionnaire on pain and one on self-perceived functional abilities. Two-thirds of the patients suffered from more than one painful joint, the ankle being mentioned most frequently (n=43). Analgesics were used by 36% of the patients indicating having pain. Six of 10 most frequently mentioned pain descriptors were of evaluative nature. Evaluative qualities of pain were associated with pain intensity, which in turn was associated with the impact of pain on daily life. Pain outcomes, after adjusting for age and treatment modality, explained 3-22% of the variance in self-perceived functional abilities. Data on radiological joint damage (Pettersson scores) were retrieved for a subgroup of 28 younger patients on prophylaxis and no significant correlations with pain parameters were found. Over two-thirds of the patients with severe haemophilia had one or more painful joints. Pain plays a small, but significant role in functional limitations. In the identified subgroup, arthropathy, as measured by the Pettersson score, seemed to have no role in pain experience. Promoting analgesic use might decrease the impact of pain on functional limitations.

Entities:  

Mesh:

Year:  2006        PMID: 16476089     DOI: 10.1111/j.1365-2516.2006.01203.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  15 in total

1.  Health care resource utilization and cost burden of hemophilia B in the United States.

Authors:  Tyler W Buckner; Iryna Bocharova; Kaitlin Hagan; Arielle G Bensimon; Hongbo Yang; Eric Q Wu; Eileen K Sawyer; Nanxin Li
Journal:  Blood Adv       Date:  2021-04-13

2.  Consecutive radiosynovectomy procedures at 6-monthly intervals behave independently in haemophilic synovitis.

Authors:  Hortensia De La Corte-Rodriguez; E Carlos Rodriguez-Merchan; Victor Jimenez-Yuste
Journal:  Blood Transfus       Date:  2012-11-20       Impact factor: 3.443

3.  [Breakthrough bleeding in adult patients with severe hemophilia A receiving low- and intermediate-dose FVIII for tertiary prophylaxis: characteristics and influencing factors].

Authors:  Shi-Qiu Qiu; Jin-Mu Zhuang; Xuan Zhou; Rui-Xue Yin; Zhu-Qin Liu; Fei Ma; Ying-Jia Li; Jing Sun
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

Review 4.  Recent advances in musculoskeletal physiotherapy for haemophilia.

Authors:  David Stephensen; Melanie Bladen; Paul McLaughlin
Journal:  Ther Adv Hematol       Date:  2018-07-02

Review 5.  [Pain therapy for children and adolescents with hemophilia : Recommendations by an expert panel].

Authors:  W Stromer; B Messerer; R Crevenna; S H Hemberger; B Jauk; R Schwarz; W Streif; K Thom; B Wagner; K Zwiauer; R Likar
Journal:  Schmerz       Date:  2018-12       Impact factor: 1.107

6.  Physiotherapy treatment in patients with hemophilia and chronic ankle arthropathy: a systematic review.

Authors:  Rubén Cuesta-Barriuso; Antonia Gómez-Conesa; José Antonio López-Pina
Journal:  Rehabil Res Pract       Date:  2013-08-12

7.  Pain and pain management in haemophilia.

Authors:  Günter Auerswald; Gerry Dolan; Anne Duffy; Cedric Hermans; Victor Jiménez-Yuste; Rolf Ljung; Massimo Morfini; Thierry Lambert; Silva Zupančić Šalek
Journal:  Blood Coagul Fibrinolysis       Date:  2016-12       Impact factor: 1.276

8.  Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII.

Authors:  Susan Kearney; Leslie J Raffini; Tan P Pham; Xin Ying Lee; Sylvia von Mackensen; Andrea Landorph; Hideyuki Takedani; Johannes Oldenburg
Journal:  Patient Prefer Adherence       Date:  2019-04-09       Impact factor: 2.711

9.  Pain Experience in Hemophilia Patients: A Hermeneutic Phenomenological Study.

Authors:  Masoume Rambod; Farkhondeh Sharif; Zahra Molazem; Kate Khair
Journal:  Int J Community Based Nurs Midwifery       Date:  2016-10

10.  A new measure to assess pain in people with haemophilia: The Multidimensional Haemophilia Pain Questionnaire (MHPQ).

Authors:  Ana Cristina Paredes; Patrício Costa; Armando Almeida; Patrícia R Pinto
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.